OLD National Bancorp IN Lowers Holdings in Bath & Body Works, Inc. (NYSE:BBWI)

OLD National Bancorp IN cut its stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 8.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 295,586 shares of the company's stock after selling 26,028 shares during the quarter. OLD National Bancorp IN owned approximately 0.13% of Bath & Body Works worth $12,757,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of BBWI. Front Row Advisors LLC bought a new position in Bath & Body Works during the third quarter worth about $25,000. Trust Co. of Vermont bought a new position in Bath & Body Works during the third quarter worth about $27,000. Denali Advisors LLC bought a new position in Bath & Body Works during the fourth quarter worth about $27,000. Money Concepts Capital Corp increased its position in Bath & Body Works by 1,180.4% during the fourth quarter. Money Concepts Capital Corp now owns 653 shares of the company's stock worth $28,000 after acquiring an additional 602 shares during the period. Finally, Turtle Creek Wealth Advisors LLC bought a new position in Bath & Body Works during the fourth quarter worth about $35,000. 95.14% of the stock is owned by institutional investors.

Bath & Body Works Stock Performance

Shares of BBWI traded up $0.13 during mid-day trading on Friday, reaching $43.99. The company had a trading volume of 2,197,997 shares, compared to its average volume of 2,416,462. The company's 50 day simple moving average is $46.15 and its 200 day simple moving average is $40.19. Bath & Body Works, Inc. has a 1-year low of $27.30 and a 1-year high of $50.34. The company has a market capitalization of $9.89 billion, a price-to-earnings ratio of 11.43, a P/E/G ratio of 1.43 and a beta of 1.86.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its earnings results on Thursday, February 29th. The company reported $2.06 EPS for the quarter, topping the consensus estimate of $1.85 by $0.21. Bath & Body Works had a net margin of 11.82% and a negative return on equity of 37.01%. The business had revenue of $2.91 billion for the quarter, compared to the consensus estimate of $2.84 billion. During the same period last year, the company earned $1.86 EPS. The firm's revenue was up .8% compared to the same quarter last year. As a group, equities analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 8th. Investors of record on Friday, February 23rd were given a dividend of $0.20 per share. The ex-dividend date was Thursday, February 22nd. This represents a $0.80 annualized dividend and a yield of 1.82%. Bath & Body Works's dividend payout ratio is presently 20.78%.

Insider Buying and Selling

In related news, insider Thomas E. Mazurek sold 4,285 shares of Bath & Body Works stock in a transaction that occurred on Wednesday, March 27th. The shares were sold at an average price of $48.89, for a total transaction of $209,493.65. Following the sale, the insider now directly owns 45,992 shares in the company, valued at approximately $2,248,548.88. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.19% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on BBWI. UBS Group raised their price target on shares of Bath & Body Works from $46.00 to $52.00 and gave the stock a "neutral" rating in a research report on Monday, March 4th. Barclays downgraded shares of Bath & Body Works from an "overweight" rating to an "equal weight" rating and increased their price objective for the stock from $37.00 to $45.00 in a research note on Thursday, January 4th. Robert W. Baird increased their price objective on shares of Bath & Body Works from $50.00 to $54.00 and gave the stock an "outperform" rating in a research note on Friday, March 1st. Telsey Advisory Group reiterated an "outperform" rating and set a $53.00 price objective on shares of Bath & Body Works in a research note on Friday, April 5th. Finally, Wells Fargo & Company increased their price objective on shares of Bath & Body Works from $40.00 to $42.00 and gave the stock an "equal weight" rating in a research note on Friday, March 1st. One research analyst has rated the stock with a sell rating, seven have given a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $46.33.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.